Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)

Anbio Biotechnology's Total Current Liabilities history runs 3 years deep, the most recent figure standing at $87836.0 for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 94.92% year-over-year to $87836.0; the TTM figure through Dec 2025 stood at $87836.0 (down 94.92% YoY), while the FY2025 annual figure was $87836.0, down 94.92% from the prior year.
• Total Current Liabilities was $87836.0 for Q4 2025 at Anbio Biotechnology, down from $131.1 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $131.1 billion in Q2 2025 to a low of $87836.0 in Q4 2025.
• Historically, Total Current Liabilities has averaged $32.8 billion across 3 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 74.23% in 2024, then slumped 94.92% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $993060.0 in 2023, then surged by 74.23% to $1.7 million in 2024, then plunged by 94.92% to $87836.0 in 2025.
• The last three Total Current Liabilities figures came in at $87836.0 (Q4 2025), $131.1 billion (Q2 2025), and $1.7 million (Q4 2024), per Business Quant data.